Changes in normal cells’ genetic and epigenetic makeup lead to a complex and varied disease called cancer. These alterations allow cancer cells to grow, survive, infest, and spread abnormally, making them challenging to detect and treat. The use of tumour DNA in liquid biopsies for cancer diagnosis and treatment has revolutionized the field. Historically, invasive techniques like tissue biopsies have been necessary for both diagnosing cancer and tracking its progression.